A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma

Author： Pettijohn Erin   Martone Brenda   Rademaker Alfred   Kuzel Timothy  

Publisher： MDPI

E-ISSN： 2075-4426|4|4|448-458

ISSN： 2075-4426

Source： Journal of Personalized Medicine, Vol.4, Iss.4, 2014-10, pp. : 448-458

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Platinum Combination Therapy in Pretreated Patients with Disseminated Melanoma

By  

Chemotherapy, Vol. 53, Iss. 6, 2007-10 ,pp. : 422-428

Karger

Access to resources Recommend Favorite

Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination

By  

Chemotherapy, Vol. 57, Iss. 3, 2011-05 ,pp. : 217-224

Karger

Access to resources Recommend Favorite

A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma

By Verschraegen Claire F.   Movva Sujana   Ji Yongli   Schmit Berndt   Quinn Robert H.   Liem Ben   Bocklage Therese   Shaheen Monte  

Cancers, Vol. 5, Iss. 2, 2013-04 ,pp. : 418-429

MDPI

Access to resources Recommend Favorite

A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study

By  

Chemotherapy, Vol. 61, Iss. 1, 2015-0 ,pp. : 15-22

Karger

Access to resources Recommend Favorite

Long-Term Outcomes and Prognostic Factors of High-Risk Malignant Melanoma Patients after Surgery and Adjuvant High-Dose Interferon Treatment: A Single-Center Experience

By  

Chemotherapy, Vol. 60, Iss. 4, 2015-04 ,pp. : 228-238

Karger

Access to resources Recommend Favorite